EIF3A and leukemia: Only one out of ten mice injected with p185 KO 2.3 cells developed leukemia approximately 4-month post-transplantation and two others developed solid tumors around chest (the mouse p185 KO2.3 A2, Table 1) and gastrointestinal tissues (the mouse p185 KO2.3 A1, Table 1), respectively.